{
    "code": "02022395",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022395",
    "time": "2022-08-05 21:28:07",
    "許可證字號": "衛署藥輸字第022395號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/02\/09",
    "發證日期": "88\/02\/09",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202239502",
    "中文品名": "帝拔癲凍晶注射劑４００公絲／小瓶",
    "英文品名": "DEPAKINE LYOPHILIZED INJECTION 400MG\/VIAL",
    "適應症": "無法以口服途徑控制之癲癇。",
    "劑型": "243凍晶注射劑",
    "包裝": "0.4公克小瓶瓶裝 100小瓶以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "VALPROATE SODIUM",
    "限制項目": "02輸　入",
    "申請商名稱": "1424601100  賽諾菲股份有限公司",
    "申請商地址": "台北市信義區松仁路3號7樓",
    "主製造廠": [
        {
            "製造廠名稱": "FIT0450000  Sanofi S.p.A.",
            "製造廠廠址": "Via Valcanello 4, 03012 Anagni, Italy",
            "製造廠公司地址": "",
            "製造廠國別": "ITALY",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "7770824858  台灣大昌華嘉股份有限公司",
            "製造廠廠址": "桃園市楊梅區梅獅路二段629號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠"
        },
        {
            "製造廠名稱": "FFR0211100  SANOFI-AVENTIS FRANCE S.A.",
            "製造廠廠址": "1-13, BOULEVARD ROMAIN ROLLAND 75014 PARIS, FRANCE",
            "製造廠公司地址": "",
            "製造廠國別": "FRANCE",
            "製程": "許可證持有者"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2812001310",
            "成分名稱": "VALPROATE SODIUM",
            "含量描述": "",
            "含量": "400.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Depakine 400mg Inj_box & vial-104-09-03(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022395&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "DEPAKINE IV 400mg_TWPI_C_CCDSv34-111-06-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022395&Seq=040&Type=9"
        },
        {
            "title": "Depakine IV_box_788773-109-09-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022395&Seq=013&Type=8"
        },
        {
            "title": "Depakine IV_Label_771104-109-08-27(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022395&Seq=012&Type=8"
        },
        {
            "title": "Depakine IV_Box_771100-109-08-27(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022395&Seq=011&Type=8"
        },
        {
            "title": "0903-Depakine INJ_primary packging_89032042(0903)-108-01-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022395&Seq=010&Type=8"
        },
        {
            "title": "0903-Depakine inj_Outer box_542269(0903)-108-01-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022395&Seq=009&Type=8"
        }
    ]
}